HOW IT WORKS
HOW KESIMPTA WORKS
KESIMPTA is the only B-cell treatment for RMS that’s delivered as a once-monthly* at-home auto-injection.
*Once monthly after 3 weekly starter doses.
WHAT HAPPENS IN RMS
To understand how KESIMPTA works, it’s important to know how B-cells and relapsing MS are connected.
For illustrative purposes only.
 | B-cells B-cells are a part of the immune system that help fight infections. They are found throughout the body. |
 | RMS-related B-cells In RMS, immune cells, such as B-cells, located in the lymph nodes, are mistakenly sent to attack the body's myelin—the protective covering around the nerves in the brain and spinal cord. |
KESIMPTA IS PRECISELY DELIVERED
While it is not fully understood how KESIMPTA works, it is designed to target the B-cells† in the lymph nodes believed to play a role in RMS.
Think of your body like a maze:
For illustrative purposes only.
| RMS-related B-cells As a subcutaneous injection just under the skin, KESIMPTA is thought to target a precise path to RMS-related B-cells in the lymph nodes.† |
 | B-cells The targeted delivery is thought to limit the impact on other B-cells your body needs to maintain immune function. |
†Based on preclinical studies.
ANDY M.
Dad, Account Executive
Chose KESIMPTA as 1st treatment: 2022
“Learning more about B-cell treatments and how KESIMPTA was precisely delivered made me feel more comfortable getting started.”
Up Next:
Check out the proven safety profile of KESIMPTA.
Want more info to help you decide?
Find out why so many people are choosing KESIMPTA.
Want co-pay help?
97% of all prescriptions filled have a $0 out of pocket cost when used with the Access Card.‡§
All people featured on this webpage are living with relapsing multiple sclerosis, have taken KESIMPTA, and have been compensated for their time.
RMS, relapsing multiple sclerosis.
‡Limitations apply. Offer not valid under Medicare, Medicaid, or any other federal or state health insurance program. Patients with commercial insurance who are initially denied coverage may receive free KESIMPTA for up to 12 months while seeking coverage. Patients with commercial insurance who have coverage for KESIMPTA may receive up to $18,000 in annual co-pay benefits. Novartis reserves the right to rescind, revoke, or amend this program without notice. Additional limitations may apply. See complete Terms & Conditions at start.kesimpta.com.
§2024 data on file.